100 related articles for article (PubMed ID: 26402737)
1. Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection.
Costa RF; Longatto-Filho A; Pinheiro C; Zeferino LC; Fregnani JH
PLoS One; 2015; 10(9):e0138945. PubMed ID: 26402737
[TBL] [Abstract][Full Text] [Related]
2. The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index.
Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
Cancer Prev Res (Phila); 2020 Mar; 13(3):299-308. PubMed ID: 31836602
[TBL] [Abstract][Full Text] [Related]
3. Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.
Costa RFA; Longatto-Filho A; de Lima Vazquez F; Pinheiro C; Zeferino LC; Fregnani JHTG
BMC Cancer; 2018 Feb; 18(1):126. PubMed ID: 29394915
[TBL] [Abstract][Full Text] [Related]
4. [Cervical cancer screening in the State of Maranhão, Brazil].
Silva DS; Silva AM; Brito LM; Gomes SR; Nascimento Mdo D; Chein MB
Cien Saude Colet; 2014 Apr; 19(4):1163-70. PubMed ID: 24820599
[TBL] [Abstract][Full Text] [Related]
5. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test.
Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A
Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cervical cytological abnormalities according to the Human Development Index in the northeast region of Brazil.
Pinho-França JR; Chein MBDC; Thuler LCS
BMC Womens Health; 2016 Aug; 16():54. PubMed ID: 27516107
[TBL] [Abstract][Full Text] [Related]
7. Quality Indicators of Cervical Cytopathology Tests in the Public Service in Minas Gerais, Brazil.
Tobias AH; Amaral RG; Diniz EM; Carneiro CM
Rev Bras Ginecol Obstet; 2016 Feb; 38(2):65-70. PubMed ID: 26883863
[TBL] [Abstract][Full Text] [Related]
8. Internal quality control indicators of cervical cytopathology exams performed in laboratories monitored by the External Quality Control Laboratory.
Ázara CZ; Manrique EJ; Tavares SB; de Souza NL; Amaral RG
Rev Bras Ginecol Obstet; 2014 Sep; 36(9):398-403. PubMed ID: 25272360
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011).
Vīberga I; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):27-30. PubMed ID: 23674182
[TBL] [Abstract][Full Text] [Related]
10. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
11. [Cervical cancer screening in Hungary--epidemiologic, historical and methodologic aspects].
Langmár Z; Németh M; Kornya L
Orv Hetil; 2011 Dec; 152(51):2063-6. PubMed ID: 22130204
[TBL] [Abstract][Full Text] [Related]
12. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.
Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L
Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155
[TBL] [Abstract][Full Text] [Related]
13. Could alarmingly high rates of negative diagnoses in remote rural areas be minimized with liquid-based cytology? Preliminary results from the RODEO Study Team.
Fregnani JH; Scapulatempo C; Haikel RL; Saccheto T; Campacci N; Mauad EC; Longatto-Filho A;
Acta Cytol; 2013; 57(1):69-74. PubMed ID: 23221353
[TBL] [Abstract][Full Text] [Related]
14. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
15. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
16. [Why does the prevalence of cytopathological results of cervical cancer screening can vary significantly between two regions of Brazil?].
Discacciati MG; Barboza BM; Zeferino LC
Rev Bras Ginecol Obstet; 2014 May; 36(5):192-7. PubMed ID: 25003469
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for cervicography in the detection of premalignant lesions of the uterine cervix?: a Brazilian experience.
Gasperin P; Francisco JA; Tizzot EL; Curcio L; Couto Filho Jd; Moreira PR; Pascotini CM; de Azevedo EM; Coibion M; Budel VM; de Carvalho NS
J Low Genit Tract Dis; 2012 Oct; 16(4):387-93. PubMed ID: 22659773
[TBL] [Abstract][Full Text] [Related]
19. [Community-based cervical cancer screening in seven townships in Taiwan].
Chen CJ; You SL; Pwu RF; Wang LY; Lin YP; Hsi GC; Hsi MS; Ho HC; Lee CT; Lin CG
J Formos Med Assoc; 1995 Dec; 94 Suppl 2():S103-11. PubMed ID: 8672938
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
